A Phase II Study Analyzing Pre-Operative Stereotactic Radiosurgery Followed by Resection for Patients with 1-4 Brain Metastases
This is a prospective, single arm, phase II trial to determine the local control at 6 months utilizing pre-operative stereotactic radiosurgery followed by surgery within 1 - 3 days in subjects with a diagnosis of 1-4 brain metastases and with an indication for surgical resection of at least one brain metastasis at the discretion of a neurosurgeon.
The purpose of this study is to evaluate 6 month in-brain local control utilizing pre-operative stereotactic radiosurgery followed by surgical resection for brain metastases.
Participants will not be paid for their participation.
- IRB Number: 1707314702 (IUSCC-0627)
- Research Study Identifier: TX8397
- Principal Investigator: Gordon Watson, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required